Fidelity Investments
PLRX icon

Fidelity Investments’s Pliant Therapeutics PLRX Stock Holding History

Fidelity Investments’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$478 Sell
419
-105
-20% -$128 ﹤0.01% 5315
2026
Q1 		$660 Sell
524
-1,410
-73% -$1.78K ﹤0.01% 5137
2025
Q4 		$2.36K Sell
1,934
-3,040
-61% -$4.57K ﹤0.01% 4996
2025
Q3 		$7.36K Sell
4,974
-1,533
-24% -$2.34K ﹤0.01% 4685
2025
Q2 		$7.55K Sell
6,507
-15,703
-71% -$22.2K ﹤0.01% 4609
2025
Q1 		$30K Sell
22,210
-3,854,388
-99% -$23.4M ﹤0.01% 4076
2024
Q4 		$51.1M Sell
3,876,598
-22,883
-0.6% -$312K ﹤0.01% 1373
2024
Q3 		$43.7M Sell
3,899,481
-12,278
-0.3% -$154K ﹤0.01% 1433
2024
Q2 		$42.1M Sell
3,911,759
-34,738
-0.9% -$448K ﹤0.01% 1378
2024
Q1 		$58.8M Sell
3,946,497
-16,921
-0.4% -$279K ﹤0.01% 1265
2023
Q4 		$71.8M Sell
3,963,418
-177,586
-4% -$2.7M 0.01% 1147
2023
Q3 		$71.8M Sell
4,141,004
-101,019
-2% -$1.75M 0.01% 1111
2023
Q2 		$76.9M Sell
4,242,023
-289,492
-6% -$6.85M 0.01% 1104
2023
Q1 		$121M Buy
4,531,515
+138,284
+3% +$3.94M 0.01% 919
2022
Q4 		$84.9M Sell
4,393,231
-1,693,262
-28% -$35.4M 0.01% 1031
2022
Q3 		$127M Buy
6,086,493
+2,744,222
+82% +$52.5M 0.01% 868
2022
Q2 		$26.8M Sell
3,342,271
-1,733,054
-34% -$11.1M ﹤0.01% 1537
2022
Q1 		$35.6M Sell
5,075,325
-330,524
-6% -$3.37M ﹤0.01% 1539
2021
Q4 		$73M Buy
5,405,849
+15,159
+0.3% +$241K 0.01% 1261
2021
Q3 		$91M Buy
5,390,690
+6,522
+0.1% +$138K 0.01% 1146
2021
Q2 		$157M Buy
5,384,168
+23,440
+0.4% +$730K 0.01% 913
2021
Q1 		$211M Buy
5,360,728
+38,572
+0.7% +$1.25M 0.02% 767
2020
Q4 		$121M Buy
5,322,156
+5,640
+0.1% +$141K 0.01% 951
2020
Q3 		$120M Sell
5,316,516
-16,185
-0.3% -$404K 0.01% 826
2020
Q2 		$173M Buy
+5,332,701
New +$142M 0.02% 661

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Fidelity Investments's PLRX Position: Q2 2026 in Review

Fidelity Investments reduced its Pliant Therapeutics (PLRX) stake by 20% in Q2 2026, selling an estimated $128 and leaving 419 shares worth $478. The position accounts for ﹤0.01% of the portfolio, ranked #5315.

Fidelity Investments first reported a position in PLRX in Q2 2020 and has held it in 25 quarters since. The position peaked at $211M in Q1 2021. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • Fidelity Investments held 419 shares of Pliant Therapeutics worth $478 as of Q2 2026.
  • Fidelity Investments sold 105 Pliant Therapeutics shares in Q2 2026, an estimated $128.
  • Pliant Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5315 holding.
  • Fidelity Investments first reported a position in Pliant Therapeutics in Q2 2020 and has held it in 25 quarters since.
  • Fidelity Investments's Pliant Therapeutics position peaked at $211M in Q1 2021.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.